Relationship of ApoE Polymorphism with Lipoprotein(a), ApoA, ApoB and Lipid Levels in Atherosclerotic Infarct
Overview
Authors
Affiliations
Background And Purpose: Apolipoprotein E (apoE) polymorphism is suggested to be a risk factor in stroke in some populations, either by affecting lipid parameters or independently. Its effect on lipoprotein(a) [Lp(a)] is not known. The roles of apoE polymorphism and of high Lp(a) levels in atherosclerotic stroke (AS) in the Turkish population are unclear. Our aim was to investigate the relationship of apoE alleles and Lp(a) level with AS and the relationship of apoE alleles with Lp(a) and other lipid parameters.
Methods: ApoE polymorphisms and lipid parameters were prospectively evaluated in 85 patients and 77 controls with normal brain imaging.
Results: Only hypertension, diabetes mellitus, associated vascular diseases and decreased high-density lipoprotein cholesterol levels were found to be independent risk factors for stroke. However, in the presence of apoE/E4 allele, increased low-density lipoprotein cholesterol (LDL-chol), apolipoprotein B (apoB) and Lp(a) levels and in the presence of apo E/E3 allele, only Lp(a) levels were determined as risk factors.
Conclusion: This study showed that while apoE polymorphism was not a risk factor itself, high Lp(a), LDL-chol and apoB were determined to be risk factors in E3 or E4 carriers.
Gene ε4 Allele is Associated with Atherosclerosis in Multiple Vascular Beds.
Lin Y, Yang M, Liu Q, Cai Y, Zhang Z, Xu C Int J Gen Med. 2024; 17:5039-5048.
PMID: 39512258 PMC: 11542474. DOI: 10.2147/IJGM.S475771.
Wang Y, Yang S, Zhang S, Lu X, Ma W Pharmgenomics Pers Med. 2023; 16:303-312.
PMID: 37051559 PMC: 10083142. DOI: 10.2147/PGPM.S404663.
Qiao S, Shang K, Chu Y, Yu H, Chen X, Qin C Dis Markers. 2022; 2022:1407183.
PMID: 35154509 PMC: 8831053. DOI: 10.1155/2022/1407183.
Kumar P, Swarnkar P, Misra S, Nath M Sci Rep. 2021; 11(1):15660.
PMID: 34341405 PMC: 8329213. DOI: 10.1038/s41598-021-95141-0.
Association of apoE gene polymorphisms with lipid metabolism in renal diseases.
Zhou T, Li H, Zhong H, Zhong Z, Lin S Afr Health Sci. 2021; 20(3):1368-1381.
PMID: 33402986 PMC: 7751546. DOI: 10.4314/ahs.v20i3.43.